Stockscreener 앱 받기
1.34
0.74%
-0.01
전일 마감가:
$1.35
열려 있는:
$1.37
하루 거래량:
113.15K
Relative Volume:
0.11
시가총액:
$17.70M
수익:
-
순이익/손실:
$-7.51M
주가수익비율:
-1.0152
EPS:
-1.32
순현금흐름:
$-8.02M
1주 성능:
+3.08%
1개월 성능:
+14.53%
6개월 성능:
+6.35%
1년 성능:
+94.99%
1일 변동 폭
$1.30
$1.39
1주일 범위
$1.21
$1.41
52주 변동 폭
$0.58
$3.80
Hoth Therapeutics Inc Stock (HOTH) Company Profile
명칭
Hoth Therapeutics Inc
전화
(646)756-2997
주소
1177 AVENUE OF THE AMERICAS, NEW YORK, NY
HOTH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HOTH
Hoth Therapeutics Inc
|
1.34 | 17.17M | 0 | -7.51M | -8.02M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
466.74 | 120.29B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
553.95 | 60.26B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.71 | 43.10B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
677.39 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
302.35 | 33.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Hoth Therapeutics Inc Stock (HOTH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2019-10-15 | 개시 | The Benchmark Company | Speculative Buy |
Hoth Therapeutics Inc 주식(HOTH)의 최신 뉴스
What are the latest earnings results for Hoth Therapeutics Inc.Wealth Building Picks That Work - jammulinksnews.com
What makes Hoth Therapeutics Inc. stock price move sharplyBest Dividend Data Feed To Watch Now - jammulinksnews.com
Hoth Therapeutics Engages ICON to Expand Clinical Trial for HT-001 - Contract Pharma
Hoth Therapeutics Inc. Flashes Rebound Signal in Oversold ConditionInvestment Strategy Designed for Capital Protection - metal.it
Hoth Therapeutics to expand phase II trial of HT-001 to EU countries - Investing.com Australia
Cancer Treatment Breakthrough: Hoth Therapeutics Takes Phase II Trial Global with Major EU Expansion - Stock Titan
What is the dividend policy of Hoth Therapeutics Inc. stockDaily Trading Forecasts From AI Tools - jammulinksnews.com
What is the risk reward ratio of investing in Hoth Therapeutics Inc. stockInvest smarter with expert trading signals - jammulinksnews.com
What catalysts could drive Hoth Therapeutics Inc. stock higher in 2025Explosive market performance - jammulinksnews.com
When is Hoth Therapeutics Inc. stock expected to show significant growthDynamic portfolio growth - jammulinksnews.com
How strong is Hoth Therapeutics Inc. company’s balance sheetSuperior trading gains - jammulinksnews.com
What institutional investors are buying Hoth Therapeutics Inc. stockFind market-beating stocks for your portfolio - jammulinksnews.com
Why is Hoth Therapeutics Inc. stock attracting strong analyst attentionGrow your wealth steadily and securely - jammulinksnews.com
What analysts say about Hoth Therapeutics Inc. stockFree Wealth Management Insights - Autocar Professional
What drives Hoth Therapeutics Inc. stock priceFree Trading Strategy Suggestions - Autocar Professional
Is Hoth Therapeutics Inc. a good long term investmentTriple returns potential - PrintWeekIndia
Hoth Therapeutics Inc. Stock Analysis and ForecastHigh-yield trading alerts - Autocar Professional
Hoth Therapeutics shares fall 1.52% intraday after signing VA research deal to advance GDNF as breakthrough therapy for obesity and fatty liver. - AInvest
Hoth Therapeutics partners with VA to test GDNF therapy for obesity - Investing.com Nigeria
Hoth Therapeutics partners with VA to test GDNF therapy for obesity By Investing.com - Investing.com South Africa
New Weight Loss Drug Challenger GDNF Takes On Semaglutide in Landmark VA Obesity Study - Stock Titan
Why Hoth Therapeutics Inc. stock attracts strong analyst attentionElite Investor Club - Newser
How Hoth Therapeutics Inc. stock performs during market volatilitySwing Trade Signals - Newser
Hoth Therapeutics (NASDAQ:HOTH) Upgraded by Wall Street Zen to Hold Rating - Defense World
Hoth Therapeutics Inc (HOTH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.69%
0.79%
자본화:
|
볼륨(24시간):